Controlled trial of exchange-transfusion therapy in fulminant hepatitis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D006506:Hepatitis A / Q000150:complications / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000627:therapeutic use; D011517:Prothrombin Time
D003404:Creatinine; D000410:Alanine Transaminase; D009355:Neomycin; D001663:Bilirubin; D006854:Hydrocortisone